Works by Huang, Chen-Lung

Results: 5

Shielding analysis of the proton therapy facility at China Medical University Hospital: comparison of a simplified approach with Monte Carlo simulations.
Published in:
Radiation Protection Dosimetry, 2023, v. 199, n. 15, p. 1947, doi. 10.1093/rpd/ncac241
By:
- Hsieh, Ying-I;
- Lai, Bo-Lun;
- Shiau, An-Cheng;
- Chen, Huang-Lung;
- Sheu, Rong-Jiun
Publication type:
Article
Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival.
Published in:
2000
By:
- King, Kuang-Liang;
- Li, Anna F-Y;
- Chau, Gar-Yang;
- Chi, Chin-Wen;
- Wu, Chew-Wun;
- Huang, Chen-Lung;
- Lui, Wing-Yiu;
- King, K L;
- Li, A F;
- Chau, G Y;
- Chi, C W;
- Wu, C W;
- Huang, C L;
- Lui, W Y
Publication type:
journal article
Protective Effect of CXCR4 Antagonist DBPR807 against Ischemia-Reperfusion Injury in a Rat and Porcine Model of Myocardial Infarction: Potential Adjunctive Therapy for Percutaneous Coronary Intervention.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11730, doi. 10.3390/ijms231911730
By:
- Yeh, Kai-Chia;
- Lee, Chia-Jui;
- Song, Jen-Shin;
- Wu, Chien-Huang;
- Yeh, Teng-Kuang;
- Wu, Szu-Huei;
- Hsieh, Tsung-Chin;
- Chen, Yen-Ting;
- Tseng, Huan-Yi;
- Huang, Chen-Lung;
- Chen, Chiung-Tong;
- Jan, Jiing-Jyh;
- Chou, Ming-Chen;
- Shia, Kak-Shan;
- Chiang, Kuang-Hsing
Publication type:
Article
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents.
Published in:
Investigational New Drugs, 2012, v. 30, n. 1, p. 164, doi. 10.1007/s10637-010-9547-7
By:
- Li, Wen-Tai;
- Hwang, Der-Ren;
- Song, Jen-Shin;
- Chen, Ching-Ping;
- Chen, Tung-Wei;
- Lin, Chi-Hung;
- Chuu, Jiunn-Jye;
- Lien, Tzu-Wen;
- Hsu, Tsu-An;
- Huang, Chen-Lung;
- Tseng, Huan-Yi;
- Lin, Chu-Chung;
- Lin, Heng-Liang;
- Chang, Chung-Ming;
- Chao, Yu-Sheng;
- Chen, Chiung-Tong
Publication type:
Article
BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.
Published in:
Cancer Science, 2011, v. 102, n. 1, p. 182, doi. 10.1111/j.1349-7006.2010.01744.x
By:
- Hu, Chih-Bo;
- Chen, Ching-Ping;
- Yeh, Teng-Kuang;
- Song, Jen-Shin;
- Chang, Chi-Yen;
- Chuu, Jiunn-Jye;
- Tung, Fei-Feng;
- Ho, Pei-Yin;
- Chen, Tung-Wei;
- Lin, Chi-Hung;
- Wang, Min-Hsien;
- Chang, Kai-Yen;
- Huang, Chen-Lung;
- Lin, Heng-Liang;
- Li, Wen-Tai;
- Hwang, Der-Ren;
- Chern, Jyh-Haur;
- Hwang, Ling-Ling;
- Chang, Jang-Yang;
- Chao, Yu-Sheng
Publication type:
Article

Works by Huang, Chen-Lung

Shielding analysis of the proton therapy facility at China Medical University Hospital: comparison of a simplified approach with Monte Carlo simulations.

Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival.

Protective Effect of CXCR4 Antagonist DBPR807 against Ischemia-Reperfusion Injury in a Rat and Porcine Model of Myocardial Infarction: Potential Adjunctive Therapy for Percutaneous Coronary Intervention.

Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents.

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities.